"Leukemia, Prolymphocytic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.
| Descriptor ID |
D015463
|
| MeSH Number(s) |
C04.557.337.428.565 C15.604.515.560.550 C20.683.515.528.565
|
| Concept/Terms |
Leukemia, Prolymphocytic- Leukemia, Prolymphocytic
- Prolymphocytic Leukemia
- Leukemias, Prolymphocytic
- Prolymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Prolymphocytic".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Prolymphocytic".
This graph shows the total number of publications written about "Leukemia, Prolymphocytic" by people in this website by year, and whether "Leukemia, Prolymphocytic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 2 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Prolymphocytic" by people in Profiles.
-
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia. 2023 09; 37(9):1919-1921.
-
From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature. Ann Diagn Pathol. 2023 Feb; 62:152077.
-
Molecular characterization of Novel ATM fusions in chronic lymphocytic leukemia and T-cell prolymphocytic leukemia. Leuk Lymphoma. 2022 04; 63(4):865-875.
-
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL). Leuk Lymphoma. 2020 02; 61(2):445-449.
-
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol. 2012 Jun; 91(6):863-73.
-
Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk. 2011 Dec; 11(6):498-506.
-
Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. Biol Blood Marrow Transplant. 2010 Apr; 16(4):543-7.
-
High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood. 2008 Jan 01; 111(1):328-37.
-
Skin involvement in T-cell prolymphocytic leukemia. J Am Acad Dermatol. 2007 Sep; 57(3):533-4.
-
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2006 Sep 01; 12(17):5165-73.